# Neurovia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neurovia

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: www.neurovia-inc.com
- Total disclosed funding: $14M
- Latest round: Series A (Jul 20, 2017)
- Investors on record: 4

## About

Established in 2013 and based in California, US, Neurovia, Inc. develops therapies to treat rare genetic neurological diseases.

## Funding rounds

- Series A, Jul 20, 2017, $14M — Novartis Venture Fund, Sanofi Ventures, Enso Ventures, BioMed Ventures

## Investors

- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series A
- Sanofi Ventures (https://capitalatlas.ai/funds/sanofi-ventures) — Series A
- Enso Ventures (https://capitalatlas.ai/funds/enso-ventures) — Series A
- BioMed Ventures — Series A